These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29771698)

  • 1. Updates in colorectal cancer screening in inflammatory bowel disease.
    Clarke WT; Feuerstein JD
    Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
    Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
    Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
    Shergill AK; Farraye FA
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
    Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of patients with inflammatory bowel disease.
    Yu JX; East JE; Kaltenbach T
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Flynn AD; Valentine JF
    Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
    Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
    Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A; Bielecki C; Schmidt C
    Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
    Galanopoulos M; Tsoukali E; Gkeros F; Vraka M; Karampekos G; Matzaris GJ
    World J Gastrointest Endosc; 2018 Oct; 10(10):250-258. PubMed ID: 30364842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 16. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
    Pulusu SSR; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
    Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.